Evidence map›Paper›PMID 25830474›Full record

ArticlePloS one2015

Role of mannose-binding lectin deficiency in HIV-1 and schistosoma infections in a rural adult population in Zimbabwe.

Rutendo B L Zinyama-Gutsire, Charles Chasela, Hans O Madsen, Simbarashe Rusakaniko, Per Kallestrup, Michael Christiansen, Exnevia Gomo, Henrik Ullum, Christian Erikstrup, Shungu Munyati and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 4 countries.

Rutendo B L Zinyama-GutsireFaculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa; Medical Research Council of Zimbabwe, Ministry of Health and Child Welfare, Harare, Zimbabwe; Letten Research Foundation, Harare, Zimbabwe.
Charles ChaselaFaculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
Hans O MadsenTissue typing Laboratory, Department of Clinical Immunology, Rigshospitalet, Copenhagen, Denmark.
Simbarashe RusakanikoLetten Research Foundation, Harare, Zimbabwe; University of Zimbabwe, College of Health Sciences, Harare, Zimbabwe.
Per KallestrupCentre for Global Health, Department of Public Health, Aarhus University, Aarhus, Denmark.
Michael ChristiansenDepartment of Clinical Biochemistry, Immunology and Genetics, Statens Serum Institute, Copenhagen, Denmark.
Exnevia GomoDepartment of Medical Laboratory Sciences, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
Henrik UllumDepartment of Medical Laboratory Sciences, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
Christian ErikstrupTissue typing Laboratory, Department of Clinical Immunology, Rigshospitalet, Copenhagen, Denmark.
Shungu MunyatiBiomedical Research and Training Institute, Harare, Zimbabwe.
Edith N KurewaLetten Research Foundation, Harare, Zimbabwe; University of Zimbabwe, College of Health Sciences, Harare, Zimbabwe.
Babill Stray-PedersenDivision of Women and Children, Rigshospitalet Oslo University Hospital and University of Oslo, Oslo, Norway, and Letten Research Foundation, Harare, Zimbabwe; University of Zimbabwe, College of Health Sciences, Harare, Zimbabwe.
Peter GarredLaboratory of Molecular Medicine, Department of Clinical Immunology, Copenhagen University, Rigshospitalet, Copenhagen, Denmark.
Takafira MduluzaUniversity of Zimbabwe, Biochemistry Department, Harare, Zimbabwe, and Department of Laboratory Medicine and Medical Sciences, University of KwaZulu Natal, Durban, South Africa.
University of Zimbabwe · ZWRigshospitalet · DKAarhus University · DKBiomedical Research and Training Institute · ZWMinistry of Health and Child Welfare · ZWStatens Serum Institut · DKUniversity of the Witwatersrand · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPolymorphism in the MBL2 gene lead to MBL deficiency, which has been shown to increase susceptibility to various bacterial, viral and parasitic infections. We assessed role of MBL deficiency in HIV-1 and schistosoma infections in Zimbabwean adults enrolled in the Mupfure Schistosomiasis and HIV Cohort (MUSH Cohort).

methodsHIV-1, S. haematobium and S. mansoni infections were determined at baseline. Plasma MBL concentration was measured by ELISA and MBL2 genotypes determined by PCR. We calculated and compared the proportions of plasma MBL deficiency, MBL2 structural variant alleles B (codon 54A>G), C (codon 57A>G), and D (codon 52T>C) as well as MBL2 promoter variants -550(H/L), -221(X/Y) and +4(P/Q) between HIV-1 and schistosoma co-infection and control groups using Chi Square test.

resultsWe assessed 379 adults, 80% females, median age (IQR) 30 (17-41) years. HIV-1, S. haematobium and S. mansoni prevalence were 26%, 43% and 18% respectively in the MUSH baseline survey. Median (IQR) plasma MBL concentration was 800μg/L (192-1936μg/L). Prevalence of plasma MBL deficiency was 18% with high frequency of the C (codon 57G>A) mutant allele (20%). There was no significant difference in median plasma MBL levels between HIV negative (912μg/L) and HIV positive (688μg/L), p = 0.066. However plasma MBL levels at the assay detection limit of 20μg/L were more frequent among the HIV-1 infected (p = 0.007). S. haematobium and S. mansoni infected participants had significantly higher MBL levels than uninfected. All MBL2 variants were not associated with HIV-1 infection but promoter variants LY and LL were significantly associated with S. haematobium infection.

conclusionOur data indicate high prevalence of MBL deficiency, no evidence of association between MBL deficiency and HIV-1 infection. However, lower plasma MBL levels were protective against both S. haematobium and S. mansoni infections and MBL2 promoter and variants LY and LL increased susceptibility to S. haematobium infection.

Indexed as

HIV-1AdolescentAdultCoinfectionFemaleGene FrequencyGenetic Association StudiesGenetic Predisposition to DiseaseHIV InfectionsHumansMaleMannose-Binding LectinMetabolism, Inborn ErrorsPolymorphism, Single NucleotidePrevalencePromoter Regions, GeneticMannose-Binding LectinMBL2 protein, human

Identifiers

PMID25830474
PMCPMC4382150
OpenAlexW2056755277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.